BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28712700)

  • 21. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
    Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
    J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
    Xu HD; Zhang YQ
    Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality computer-aided breast cancer diagnosis with FFDM and DCE-MRI.
    Yuan Y; Giger ML; Li H; Bhooshan N; Sennett CA
    Acad Radiol; 2010 Sep; 17(9):1158-67. PubMed ID: 20692620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new algorithm for automatic vascular mapping of DCE-MRI of the breast: Clinical application of a potential new biomarker.
    Vignati A; Giannini V; Carbonaro LA; Bertotto I; Martincich L; Sardanelli F; Regge D
    Comput Methods Programs Biomed; 2014 Dec; 117(3):482-8. PubMed ID: 25262335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
    Fan M; Zhang P; Wang Y; Peng W; Wang S; Gao X; Xu M; Li L
    Eur Radiol; 2019 Aug; 29(8):4456-4467. PubMed ID: 30617495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer-based automated estimation of breast vascularity and correlation with breast cancer in DCE-MRI images.
    Kostopoulos SA; Vassiou KG; Lavdas EN; Cavouras DA; Kalatzis IK; Asvestas PA; Arvanitis DL; Fezoulidis IV; Glotsos DT
    Magn Reson Imaging; 2017 Jan; 35():39-45. PubMed ID: 27569368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
    Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
    Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
    Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
    Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
    Jun W; Cong W; Xianxin X; Daqing J
    Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computer-aided diagnosis system for breast DCE-MRI at high spatiotemporal resolution.
    Dalmış MU; Gubern-Mérida A; Vreemann S; Karssemeijer N; Mann R; Platel B
    Med Phys; 2016 Jan; 43(1):84. PubMed ID: 26745902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer-aided diagnosis of breast DCE-MRI images using bilateral asymmetry of contrast enhancement between two breasts.
    Yang Q; Li L; Zhang J; Shao G; Zhang C; Zheng B
    J Digit Imaging; 2014 Feb; 27(1):152-60. PubMed ID: 24043592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features.
    Giannini V; Mazzetti S; Marmo A; Montemurro F; Regge D; Martincich L
    Br J Radiol; 2017 Aug; 90(1077):20170269. PubMed ID: 28707546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Subtypes Recognition of Breast Cancer in Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Phenotypes from Radiomics Data.
    Li W; Yu K; Feng C; Zhao D
    Comput Math Methods Med; 2019; 2019():6978650. PubMed ID: 31827586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
    Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
    BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
    Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
    Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A computerized global MR image feature analysis scheme to assist diagnosis of breast cancer: a preliminary assessment.
    Yang Q; Li L; Zhang J; Shao G; Zheng B
    Eur J Radiol; 2014 Jul; 83(7):1086-1091. PubMed ID: 24743001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
    Kang DK; Kim TH; Han TS; Kim KS; Yim H
    J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.